Millendo Therapeutics

Views & Analysis

Rare disease specialists Millendo Therapeutics are hoping their drug livoletide will become the first treatment for Prader-Willi syndrome.

News

The UK has teamed up with Eli Lilly on initiatives, backed with £85 million in funding, to expand access to treatment for obesity.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.